# AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke

Study · id `cardio:ct-nct03192215` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03192215](<https://clinicaltrials.gov/study/NCT03192215>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT03192215

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 1015 participants.

## Technical summary

Registry record NCT03192215. Randomized; quadruple masking; primary purpose prevention. Start 2018-01-19 (actual); primary completion 2023-03-31 (actual). Results posted on 2025-04-09.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 1015 participants (enrolled count; ClinicalTrials.gov record NCT03192215, source copy `cardio:ctgov-nct03192215-2025-04-09`, retrieved 2026-10-31)
- Started: 2018-01-19 (actual) (ClinicalTrials.gov record NCT03192215, source copy `cardio:ctgov-nct03192215-2025-04-09`, retrieved 2026-10-31)
- Primary completion: 2023-03-31 (actual) (ClinicalTrials.gov record NCT03192215, source copy `cardio:ctgov-nct03192215-2025-04-09`, retrieved 2026-10-31)
- Completion: 2023-04-17 (actual) (ClinicalTrials.gov record NCT03192215, source copy `cardio:ctgov-nct03192215-2025-04-09`, retrieved 2026-10-31)
- Results first posted: 2025-04-09 (ClinicalTrials.gov record NCT03192215, source copy `cardio:ctgov-nct03192215-2025-04-09`, retrieved 2026-10-31)
- Countries: United States; Canada (ClinicalTrials.gov record NCT03192215, source copy `cardio:ctgov-nct03192215-2025-04-09`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03192215-2025-04-09`, retrieved 2026-10-31)

## The registry's words

- Brief title: AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
- Acronym: ARCADIA
- Condition: Stroke
- Intervention (Drug): Apixaban
- Intervention (Drug): Aspirin
- Lead sponsor: Columbia University
- Lead sponsor class: OTHER
- Collaborator: National Institute of Neurological Disorders and Stroke (NINDS)
- Collaborator class: NIH
- Collaborator: University of Cincinnati
- Collaborator class: OTHER
- Collaborator: Medical University of South Carolina
- Collaborator class: OTHER
- Collaborator: Bristol-Myers Squibb
- Collaborator class: INDUSTRY
- Collaborator: Pfizer
- Collaborator class: INDUSTRY
- Collaborator: Roche Pharma AG
- Collaborator class: INDUSTRY
- Collaborator: Weill Medical College of Cornell University
- Collaborator class: OTHER
- Collaborator: University of Washington
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Apixaban (`cardio:apixaban`)
- Registry intervention name matches this record: Aspirin (`core:aspirin`)
- Registry lists this organization as the lead sponsor: Columbia University (`cardio:org-columbia-university`)
- Registry lists this organization as a collaborator: National Institute of Neurological Disorders and Stroke (`cardio:ninds`)
- Registry lists this organization as a collaborator: University of Cincinnati (`cardio:org-university-of-cincinnati`)
- Registry lists this organization as a collaborator: Medical University of South Carolina (`cardio:org-medical-university-of-south-carolina`)
- Registry lists this organization as a collaborator: Bristol-Myers Squibb (`cardio:org-bristol-myers-squibb`)
- Registry lists this organization as a collaborator: Pfizer (`cardio:org-pfizer`)
- Registry lists this organization as a collaborator: Weill Medical College of Cornell University (`cardio:org-weill-medical-college-of-cornell-university`)
- Registry lists this organization as a collaborator: University of Washington (`cardio:org-university-of-washington`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Apixaban vs Aspirin in Patients With Cancer and Cryptogenic Stroke: A Post Hoc Analysis of the ARCADIA Randomized Clinical Trial (`cardio:pubmed-39133474`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Diagnosis of Incident Cancer After Cryptogenic Stroke: An Exploratory Analysis of the ARCADIA Randomized Trial (`cardio:pubmed-39481070`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Apixaban to Prevent Covert Infarcts After Cryptogenic Stroke in Patients With Atrial Cardiopathy: A Secondary Analysis of the ARCADIA Randomized Clinical Trial (`cardio:pubmed-39869342`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: History of Cancer and Atrial Cardiopathy: A Secondary Analysis of the ARCADIA Clinical Trial (`cardio:pubmed-40265582`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Premature Atrial Contractions as a Marker of Atrial Cardiopathy: A Revised Analysis of the ARCADIA Randomized Trial (`cardio:pubmed-40294164`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Apixaban Versus Aspirin to Reduce Cognitive Decline After Cryptogenic Stroke and Atrial Cardiopathy: ARCADIA-Cognition Study (`cardio:pubmed-40847528`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Hypertension With High-Risk Features in Cryptogenic Stroke: An Exploratory Analysis of the ARCADIA Randomized Clinical Trial (`cardio:pubmed-42008258`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 1900de817370977648e43fa5569794857e39043492d52789d1ed3153d91215dc
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
